Literature DB >> 10092046

Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders.

M Sarter1, J P Bruno.   

Abstract

Cholinergic neurons originating in the basal forebrain innervate all cortical areas and participate in the gating of cortical information processing. Aberrations in the excitability of cortical cholinergic inputs fundamentally alter the processing of sensory stimuli and higher processes, thereby advancing the development of major neuropsychiatric disorders. Cortical cholinergic deafferentation has been considered to be a major neuropathological variable that contributes to the development of age- and dementia-associated impairments in cognition. Conversely, it has been suggested that increases in the excitability of cortical cholinergic inputs mediate the abnormal cognitive processes that escalate into psychotic symptoms and contribute to addictive-drug-seeking behavior, anxiety and phobia. Abnormal regulation of the excitability of cortical cholinergic afferents represents a 'final common pathway' that mediates the manifestation of major neuropsychiatric disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10092046     DOI: 10.1016/s0166-2236(98)01289-2

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  24 in total

1.  Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation.

Authors:  T M Gill; M Sarter; B Givens
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 2.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

3.  3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.

Authors:  Sunila G Nair; Gary A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  2005-12-24       Impact factor: 4.530

4.  Olanzapine causes a leptin-dependent increase in acetylcholine release in mouse prefrontal cortex.

Authors:  Asheley B Wathen; Emily S West; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

5.  mGluR7 genetics and alcohol: intersection yields clues for addiction.

Authors:  Beatrix Gyetvai; Agnes Simonyi; Melinda Oros; Mariko Saito; John Smiley; Csaba Vadász
Journal:  Neurochem Res       Date:  2011-03-30       Impact factor: 3.996

6.  Muscarinic acetylcholine receptors control baseline activity and Hebbian stimulus timing-dependent plasticity in fusiform cells of the dorsal cochlear nucleus.

Authors:  Roxana A Stefanescu; Susan E Shore
Journal:  J Neurophysiol       Date:  2016-12-21       Impact factor: 2.714

7.  Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.

Authors:  Lori A Newman; Jenna Darling; Jill McGaughy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-22       Impact factor: 4.530

8.  Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Authors:  D M Cannon; J K Klaver; S K Gandhi; G Solorio; S A Peck; K Erickson; N Akula; J Savitz; W C Eckelman; M L Furey; B J Sahakian; F J McMahon; W C Drevets
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

9.  Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting.

Authors:  J McGaughy; R S Ross; H Eichenbaum
Journal:  Neuroscience       Date:  2008-02-19       Impact factor: 3.590

Review 10.  Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Authors:  Gary A Gudelsky; Bryan K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-10-16       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.